KR102504039B9 - 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도 - Google Patents

자연살해세포 증식에 효과적인 배양 방법 및 이의 용도

Info

Publication number
KR102504039B9
KR102504039B9 KR1020220138783A KR20220138783A KR102504039B9 KR 102504039 B9 KR102504039 B9 KR 102504039B9 KR 1020220138783 A KR1020220138783 A KR 1020220138783A KR 20220138783 A KR20220138783 A KR 20220138783A KR 102504039 B9 KR102504039 B9 KR 102504039B9
Authority
KR
South Korea
Prior art keywords
proliferation
natural killer
killer cell
culture methods
novel culture
Prior art date
Application number
KR1020220138783A
Other languages
English (en)
Other versions
KR102504039B1 (ko
Inventor
오정훈
Original Assignee
오정훈
(주)포에버엔케이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오정훈, (주)포에버엔케이 filed Critical 오정훈
Priority to KR1020220138783A priority Critical patent/KR102504039B1/ko
Application granted granted Critical
Publication of KR102504039B1 publication Critical patent/KR102504039B1/ko
Publication of KR102504039B9 publication Critical patent/KR102504039B9/ko
Priority to PCT/KR2023/008642 priority patent/WO2024090703A1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020220138783A 2022-10-25 2022-10-25 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도 KR102504039B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020220138783A KR102504039B1 (ko) 2022-10-25 2022-10-25 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도
PCT/KR2023/008642 WO2024090703A1 (ko) 2022-10-25 2023-06-21 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020220138783A KR102504039B1 (ko) 2022-10-25 2022-10-25 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도

Publications (2)

Publication Number Publication Date
KR102504039B1 KR102504039B1 (ko) 2023-03-02
KR102504039B9 true KR102504039B9 (ko) 2023-05-11

Family

ID=85509067

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020220138783A KR102504039B1 (ko) 2022-10-25 2022-10-25 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도

Country Status (2)

Country Link
KR (1) KR102504039B1 (ko)
WO (1) WO2024090703A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102504039B1 (ko) * 2022-10-25 2023-03-02 오정훈 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101039843B1 (ko) * 2010-08-30 2011-06-09 주식회사 엔케이바이오 자기활성화 림프구 배양용 배지 조성물 및 이를 이용한 자기활성화 림프구 배양방법
US20150010583A1 (en) * 2012-02-08 2015-01-08 Ipd-Therapeutics B.V. Ex vivo nk cell differentiation from cd34+ hematopoietic cells
KR101683614B1 (ko) * 2016-02-15 2016-12-07 신동혁 Nk세포배양용 배지첨가키트 및 상기 키트를 이용한 nk세포배양방법
KR101969045B1 (ko) * 2016-11-22 2019-04-19 신동혁 면역세포배양용 배지첨가키트, 상기 키트를 이용한 면역세포배양방법, 상기 키트 또는 배양방법에 의해 얻어진 무혈청면역세포배양액 및 상기 배양액을 포함하는 화장료조성물
KR102233660B1 (ko) 2019-05-15 2021-03-30 (주)포에버엔케이 효율적 자연살해세포 배양방법 및 이의 배지첨가 키트
KR102445491B1 (ko) * 2021-06-30 2022-09-21 엔케이젠 주식회사 자연살해세포 배양용 배지 및 이를 이용한 자연살해세포 대량증식방법
KR102504039B1 (ko) * 2022-10-25 2023-03-02 오정훈 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도

Also Published As

Publication number Publication date
WO2024090703A1 (ko) 2024-05-02
KR102504039B1 (ko) 2023-03-02

Similar Documents

Publication Publication Date Title
SG11202100320QA (en) Therapeutic preparations of gamma-delta t cells and natural killer cells and methods for manufacture and use
PH12016502148A1 (en) Methods of microalgae cultivation for increased resource production
WO2010047475A3 (ko) 제대혈로부터 효율적인 자연살해세포의 증식 및 분화 방법
EP3850004A4 (en) NATURAL KILLER CELL COMPOSITIONS AND IMMUNOTHERAPY METHODS FOR TREATMENT OF TUMORS
EP3914274A4 (en) COMPOSITIONS AND METHODS FOR STIMULATION OF NATURAL KILLER CELLS
SG11202105213XA (en) Expansion of natural killer cells and ilc3 cells with novel aromatic compounds
EP3911340A4 (en) NOVEL CD16+ NATURAL KILLER CELL AND METHOD OF GROWING CD16+ NATURAL KILLER CELL
KR102504039B9 (ko) 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도
EP3746095A4 (en) NATURAL KILLER CELL PRODUCTION PROCESS AND COMPOSITION FOR CANCER TREATMENT
EP3927730A4 (en) EXPANSION OF NATURAL KILLER CELLS AND CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS
IL310789A (en) Persistent Allogeneic Modified Immune Cells and Methods of Using Them
IL286720A (en) Methods to reduce the levels of large-granular lymphocytes and natural killer cells
EP3765154A4 (en) MODIFICATION OF IMMUNE CELLS TO REDUCE TOXICITY AND THEIR USES IN ADOPTIVE CELL THERAPY
IL288260A (en) Preparations and methods for plant cell culture
GB202109020D0 (en) Human V#9V#2T cell proliferation culture method and culture medium
IL283882A (en) Preparations and methods for the treatment of (cutaneous t cell lymphoma (ctcl
IL286695A (en) Modulators of cell surface protein interactions and methods and compositions related thereto
EP4065691A4 (en) NATURAL KILLER CELL IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER FORMS OF CANCER
EP4096515A4 (en) METHOD AND DEVICE FOR INHIBITING THE GROWTH OF PROLIFERING CELLS OR VIRUSES
EP3802797A4 (en) METHODS FOR MAKING NATURAL KILLER CELLS AND THEIR USES
EP3967753A4 (en) PROCESS FOR CULTIVATION OF ALLOGOUS IMMUNITY CELLS, IMMUNITY CELL CULTURE OBTAINED THEREBY AND IMMUNITY CELL THERAPEUTIC THEREFORE
MX2018003141A (es) Metodo para cultivar celulas.
IL286558A (en) A method for culturing a population of cells and their use
EP4004226A4 (en) Fibrosis-specific cell culture substrate and methods of use
GB2601311B (en) Methods of in vitro culturing sphagnum

Legal Events

Date Code Title Description
G170 Re-publication after modification of scope of protection [patent]